Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Clinical trial NCT00822705 · COMPLETED

Trial details

NCT number: NCT00822705
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anti Obesity Agent

Start date: 2008-08-01
Primary completion: 2008-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.